Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$237,550,033
+$30,192,967 QoQ
Shares Held
4,365,926
-9.7% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#15
of 739 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,519,143,091 across 72 Biotechnology names. EXEL ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
738,378 | $366,774,503 | |
| 2 | INCY |
Incyte Corp
|
2,744,958 | $311,168,438 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
393,685 | $245,478,344 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
4,365,926 | $237,550,033 | |
| 5 | GMAB |
Genmab A/S
|
4,975,324 | $136,672,150 | |
| 6 | RPRX |
Royalty Pharma plc
|
2,435,341 | $136,549,569 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
1,704,623 | $133,420,842 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
249,758 | $71,173,537 |
All Filings in EXEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,550,033 | 4,365,926 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $207,357,066 | 4,834,625 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $231,302,218 | 5,277,258 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $217,565,963 | 5,267,941 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $231,977,303 | 5,262,643 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $135,942,245 | 3,682,076 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $105,207,853 | 3,159,395 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $40,116,442 | 1,545,913 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,907,757 | 1,197,497 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,001,411 | 421,467 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,906,341 | 79,464 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $4,885,623 | 304,590 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,377,291 | 151,613 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,628,159 | 942,755 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $13,396,680 | 732,860 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,336,623 | 252,442 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $470,167 | 25,805 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $14,489,195 | 721,933 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $985,995 | 40,327 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $8,984,284 | 378,445 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||